VUMC News and Communications

March 29, 2019

Vanderbilt University Medical Center to acquire Tennova Healthcare-Lebanon from Community Health Systems

Leaders of Vanderbilt University Medical Center (VUMC) today announced plans to purchase Tennova Healthcare-Lebanon, a two-campus facility licensed for 245 beds, from subsidiaries of Community Health Systems, Inc. (CHS). A definitive agreement has been signed for the sale of the facility and related businesses, including physician clinic operations and outpatient services, to VUMC.

By VUMC News and Communications
March 28, 2019

Cancer’s SOS

Stephen Fesik and colleagues are advancing cancer drug discovery with the characterization of small molecules that modulate RAS, an important target for anti-cancer therapies.

By Sanjay Mishra
March 28, 2019

Unraveling endocytosis

New discoveries by Jason MacGurn and colleagues further understanding of the complex machinery that cells use take up substances from outside the cell.

By VUMC News and Communications
Speakers at the inaugural SCRIPS Spring Symposium (Supporting Careers in Research for Interventional Physicians and Surgeons) last week were, from left, Kelle Moley, MD, senior vice president and chief scientific officer of the March of Dimes; 2018 SCRIPS Scholars Yash Choksi, MD, and Akshitkumar Mistry, MD; and Anil Rustgi, MD, the T. Grier Miller Professor of Medicine and Genetics at the University of Pennsylvania’s Perelman School of Medicine and incoming director of the Herbert Irving Comprehensive Cancer Center in New York. The SCRIPS program is supported by the Burroughs Wellcome Fund.
March 28, 2019

SCRIPS Symposium

Speakers at the inaugural SCRIPS Spring Symposium (Supporting Careers in Research for Interventional Physicians and Surgeons) last week were, from left, Kelle Moley, MD, senior vice president and chief scientific officer of the March of Dimes; 2018 SCRIPS Scholars Yash Choksi, MD, and Akshitkumar Mistry, MD; and Anil Rustgi, MD.
Ruth Lehmann, PhD, center, a world-renowned expert on the biology of germ cells, delivered last week’s Flexner Discovery Lecture. Here, she poses with Ian Macara, PhD, chair of Vanderbilt’s Department of Cell and Developmental Biology, which sponsored the lecture, and Andrea Page-McCaw, PhD.
March 28, 2019

Discovery Lecture

Ruth Lehmann, PhD, center, a world-renowned expert on the biology of germ cells, delivered last week’s Flexner Discovery Lecture.

By VUMC News and Communications
March 14, 2019

Correctly copying DNA

A precise understanding of how the enzyme topoisomerase II cuts DNA could lead to better anti-cancer therapies.

By Sanjay Mishra
March 14, 2019

LGBTQ Health Symposium

Molly Adele Brown, accompanied on guitar by Tim Angsten, sang at the Second Annual Southern LGBTQ Health Symposium to engage providers, students and community members throughout the region on ways to better serve sexual and gender minority patients and families.
By VUMC News and Communications
March 14, 2019

Hockey Fights Cancer

Ray Cruz, a patient at Monroe Carell Jr. Children’s Hospital at Vanderbilt, performed the national anthem at the Nashville Predators Hockey Fights Cancer night.
By VUMC News and Communications
March 13, 2019

Longtime Children’s Hospital chaplain Raye Nell Dyer returns to serve at LifeFlight

She joins a small cadre of other flight chaplains in the U.S.
By Jerry Jones
March 7, 2019

Congressional testimony

Vanderbilt’s Jesse Ehrenfeld, MD, MPH, right, testified Feb. 27 before the U.S. House Armed Services Committee on military policy affecting transgender service members.
By VUMC News and Communications
March 7, 2019

Voting in U.S. News “Best Hospitals” Survey Continues

The opportunity for eligible physicians to vote in U.S. News & World Report’s “Best Hospitals” survey will remain open through March. Online voting takes place on Doximity (www.doximity.com). To participate, eligible physicians must complete their survey on Doximity before the close of the voting period.
By VUMC News and Communications
February 28, 2019

Achilles’ heel for kidney cancer

The discovery that kidney cells with mutations in a certain gene are sensitive to therapies called PI3K inhibitors opens new opportunities for applying precision medicine to cancer treatment.
By VUMC News and Communications
1 … 139 140 141 142 143 … 391